IGF2 and neoplasm: IGF2R also has a high affinity for IGF ligands, particularly IGF2; however, the receptor lacks an intracellular tyrosine kinase domain that is essential for the activation of the IGF pathway, thus, the receptor acts as a “decoy” of the IGF pathway and is recognized as a tumor suppressor gene [42, 46, 47].